This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.

Storage and Handling of the Intravenous Formulation of UPTRAVI

Last Updated: 04/30/2024

SUMMARY

  • UPTRAVI for injection is available in cartons containing 1 single-dose vial and should be stored at 2°C to 8°C (36°F to 46°F).1
  • Please refer to the HOW SUPPLIED/STORAGE AND HANDLING section of the full Prescribing Information.1

PRODUCT LABELING

Storage and Handling

UPTRAVI for injection for intravenous use is supplied in a 10 mL type I glass vial closed by a stopper and sealed with an aluminum flip-off button, containing 1800 mcg of selexipag.1

UPTRAVI for injection is available in cartons containing 1 single-dose vial.1

Store the original carton containing the glass vial in a refrigerator at 2°C to 8°C (36°F to 46°F) until use in order to protect from light.1

Literature Search

A literature search of MEDLINE®, EMBASE®, BIOSIS Previews®, DERWENT® (and/or other resources, including internal/external databases) was conducted on 16 April 2024

 

References

1 UPTRAVI (selexipag) [Prescribing Information]. Titusville, NJ: Actelion Pharmaceuticals US, Inc;https://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/UPTRAVI-pi.pdf.